UK-based DefiniGEN has developed iPSC-derived cell lines that can replace primary human hepatocytes for toxicity testing and accelerate the development of novel liver-targeted therapeutics. Drugmakers ...
NEW YORK, NY, UNITED STATES, January 30, 2026 /EINPresswire.com/ -- Creative Bioarray, one of the leading providers of ...
Dublin, Feb. 12, 2020 (GLOBE NEWSWIRE) -- The "In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal ...
Newcells provides a quick and accurate in vitro retinal drug toxicity testing service using intricate retinal organoid models created in-house or from client-supplied cells. The retinal toxicity ...
In Vivo and In Silico Methods from Predictive Toxicology to Help Develop Precision Medicine Traditional in vivo animal methods for assessing safety and toxicity continue to be replaced by alternative ...
Chicago, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The global in-vitro toxicology testing market was valued at 26.00 billion in 2024 and is expected to reach US$ 57.55 billion by 2033, growing at a CAGR of ...
Creating a drug that might help treat or cure a health condition in humans is a long, complex process. After developing a ...
The "In-Vitro Toxicology Testing Market Research Report by Technology, by Method, by Application, by End-User Industry, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has ...
(MENAFN- GlobeNewsWire - Nasdaq) Growth is being fueled by stringent regulatory requirements, a global pivot toward animal-free safety assessment, and rising demand from pharmaceutical, cosmetics, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results